Camber Pharmaceuticals adds 500 count to Generic Zetia®
Piscataway, NJ, July 18, 2024 – Camber Pharmaceuticals is pleased to announce the addition of Ezetimibe 500 count to its product line.
Last August, Camber launched the 10 mg of Ezetimibe Tablets in 30 and 90 count bottles.
Ezetimibe 10 mg Tablets are now available in 30, 90 and 500 count bottles.
To find out more about Ezetimibe Tablets, USP please visit www.camberpharma.com.
Recent articles
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class
- Camber Launches 5 Generics in May






